🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary objective: * To demonstrate that 3 doses of a vaccine containing T...
Status
Completed
Location
Sanofi Pasteur MSD investigational site
Start Date
2011-01
Trial ID
NCT01287949
Treatments Being Tested
This is a study to assess the safety, tolerability, and immunogenicity of V...
Status
Completed
Location
Multiple Locations
Start Date
2011-04-19
Trial ID
NCT01337167
Treatments Being Tested
In July 2015-November 2016, a phase II/III randomized, observer-blind,contr...
Status
Completed
Location
Vaccine Trial Centre, Faculty of Tropical Medicine, Mhahidol University, 420/6 Ratchawithi Road, Ratchathewi,
Start Date
2018-06-26
Trial ID
NCT04102137
Treatments Being Tested
Objectives: * To present the rates of adverse reactions after a dose of DA...
Status
Completed
Location
Multiple Locations
Start Date
2004-02
Trial ID
NCT00802867
Treatments Being Tested
The present clinical study will assess the immunogenicity and reactogenicit...
Status
Completed
Location
Multiple Locations
Start Date
2006-04
Trial ID
NCT00319852
Treatments Being Tested
This is a global Phase 3 study to evaluate the safety and effectiveness of ...
Status
Completed
Location
The University of Alabama at Birmingham Hosptial Outreach Lab
Start Date
2019-07-18
Trial ID
NCT04006457
The aims of this trial are to demonstrate the consistency of three manufact...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-01-06
Trial ID
NCT00148941
Treatments Being Tested
The main objective is to determine whether immune responses to Tdap (GlaxoS...
Status
Completed
Location
Birmingham Pediatrics, 806 Saint Vincent's Drive, Suite 615
Start Date
2011-09
Trial ID
NCT01424644
The purpose of this study is to evaluate the safety and immunogenicity of t...
Status
Recruiting
Location
Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention
Start Date
2023-12-21
Trial ID
NCT06344065
Treatments Being Tested
The purpose of this Phase II study is to evaluate the feasibility of GSK Bi...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-06-24
Trial ID
NCT00871338
Treatments Being Tested